The last time there was a big wave of biotech acquisitions, buyers snapped up early-stage companies much more often than they did during other periods, according to a new STAT analysis.
Members of Congress appear likely to opt for a short-term extension of Medicare telehealth policies instead of permanent changes.
STAT’s Casey Ross and Bob Herman have been named 2024 Pulitzer Prize finalists. Read executive editor Rick Berke’s note to readers on the honor.
Endo “was one of the worst actors in the opioid crisis” said Andrew Kolodny of the Opioid Policy Research Collaborative at Brandeis University.
New ways of identifying and testing therapies, a more precise understanding of disease, and a renewed sense of urgency could help speed up drug development.
A boy with Duchenne muscular dystrophy died after receiving a Pfizer experimental gene therapy. The company is pausing its trial in older boys.
A boy with Duchenne muscular dystrophy died after receiving a Pfizer experimental gene therapy. The company is pausing its trial in older boys.
A House proposal includes extension of more flexible rules for telehealth and hospital home-care programs. To pay for it, it seeks new limits on pharmacy…
“Imagine the vast majority of the pediatric population where they’re not even checking blood pressure,” says the author of a study that links chidren’s hypertension…
Lobbying registrations tied to tobacco companies jumped over 10% from 2023 to 2024, and lobbyists are busy pushing and opposing laws in statehouses.
Subscribe to STAT+ and stay up-to-date on the latest trends and ground breaking discoveries in cancer research.
